Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Statement of Comprehensive Income [Abstract]        
Revenue $ 33 $ 3 $ 62 $ 8
Cost of revenue 32 62 72 65
Gross profit (loss) 1 (59) (10) (57)
Operating expenses:        
Research and development 1,160 2,173 4,359 6,706
Sales and marketing 509 1,160 2,954 3,473
General and administrative 2,155 2,028 7,432 7,189
Total operating expenses 3,824 5,361 14,745 17,368
Operating loss (3,823) (5,420) (14,755) (17,425)
Gain on change in estimated fair value of contingent royalty obligation 3 127 248 68
Finance income (expense), net (117) 95 (348) 214
Foreign currency gain (loss) (1) 3 (4) (6)
Loss before income taxes (3,938) (5,195) (14,859) (17,149)
Income tax expense
Net loss $ (3,938) $ (5,195) $ (14,859) $ (17,149)
Basic and diluted loss per common share $ (0.13) $ (0.18) $ (0.51) $ (0.72)
Weighted average number of common shares outstanding, basic and diluted 30,422,265 28,716,213 29,366,154 23,896,843